Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hermann-Josef Strotmann"'
Autor:
Matthias R. Langenfeld, Georg Lübben, Thomas Konrad, Eberhard Standl, Thomas Forst, Jan Schulze, Hermann-Josef Strotmann, C. Hohberg, Andreas Pfützner
Publikováno v:
Diabetes Technology & Therapeutics. 7:478-486
The cross-sectional IRIS-II study tried to assess the prevalence of insulin resistance and macrovascular disease in orally treated patients with Type 2 diabetes.In total, 4,270 patients were enrolled into the study (2,146 male, 2,124 female; mean +/-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05be80dda2efd394223adb8d1a39161d
https://doi.org/10.1089/dia.2005.7.478
https://doi.org/10.1089/dia.2005.7.478
Autor:
Eberhard Standl, Hermann-Josef Strotmann, Sabine Pahler, Georg Lübben, Thomas Forst, Matthias R. Langenfeld, Peter H. Kann, Andreas Pfützner
Publikováno v:
Diabetes technologytherapeutics. 6(6)
This study was performed to compare the specificity and sensitivity of intact proinsulin, adiponectin, and their ratio (proinsulin/adiponectin) in the prediction of insulin resistance as assessed by the homeostasis model assessment (HOMA) score (or =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fb3a2e2fe4ca8b7fb37b495eab9d248
https://pubmed.ncbi.nlm.nih.gov/15684637
https://pubmed.ncbi.nlm.nih.gov/15684637
Autor:
Andreas Pftzner, Eberhard Standl, Cloth Hohberg, Thomas Konrad, Hermann-Josef Strotmann, Georg Lbben, Matthias R. Langenfeld, Jan Schulze, Thomas Forst
Publikováno v:
Diabetes Technology & Therapeutics; Jun2005, Vol. 7 Issue 3, p478-486, 9p
Autor:
Matthias R. Langenfeld, Thomas Forst, Eberhard Standl, Hermann-Josef Strotmann, Georg Lübben, Sabine Pahler, Peter Kann, Andreas Pfützner
Publikováno v:
Diabetes Technology & Therapeutics; Dec2004, Vol. 6 Issue 6, p836-843, 8p